Patent assignee · US · COMPANY

ModernaTX, Inc.

227Patents
227Active
227Granted
61Portfolio score

Filing activity: Mar 9, 2013 → Jan 15, 2025

Most-cited patents

PatentTitleAreaCited byStatus
US9872900B2 Nucleic acid vaccines Emerging Cross-Sectional Technologies 144 Active
US9868691B2 Compounds and compositions for intracellular delivery of therapeutic agents Chemistry; Metallurgy 126 Active
US9597380B2 Terminally modified RNA Chemistry; Metallurgy 125 Active
US10064935B2 Human cytomegalovirus RNA vaccines Chemistry; Metallurgy 112 Active
US9512456B2 Enzymes and polymerases for the synthesis of RNA Chemistry; Metallurgy 104 Active
US10064934B2 Combination PIV3/hMPV RNA vaccines Emerging Cross-Sectional Technologies 95 Active
US10124055B2 Zika virus RNA vaccines Emerging Cross-Sectional Technologies 93 Active
US9533047B2 Delivery and formulation of engineered nucleic acids Chemistry; Metallurgy 87 Active
US10207010B2 Compositions and methods for delivery of agents Chemistry; Metallurgy 86 Active
US10273269B2 High potency immunogenic zika virus compositions Emerging Cross-Sectional Technologies 79 Active
US10465190B1 In vitro transcription methods and constructs Chemistry; Metallurgy 73 Active
US10493143B2 Sexually transmitted disease vaccines Emerging Cross-Sectional Technologies 72 Active
US10449244B2 Zika RNA vaccines Emerging Cross-Sectional Technologies 72 Active
US10286086B2 Alternative nucleic acid molecules and uses thereof Chemistry; Metallurgy 68 Active
US10695419B2 Human cytomegalovirus vaccine Emerging Cross-Sectional Technologies 66 Active
US9572896B2 In vivo production of proteins Chemistry; Metallurgy 65 Active
US10526629B2 RNA polymerase variants Chemistry; Metallurgy 65 Active
US10653767B2 Zika virus MRNA vaccines Emerging Cross-Sectional Technologies 65 Active
US10653712B2 High purity RNA compositions and methods for preparation thereof Physics 63 Active
US10925958B2 Influenza vaccine Chemistry; Metallurgy 59 Active
US9587003B2 Modified polynucleotides for the production of oncology-related proteins and peptides Chemistry; Metallurgy 59 Active
US10385088B2 Polynucleotide molecules and uses thereof Chemistry; Metallurgy 58 Active
US9868692B2 Compounds and compositions for intracellular delivery of therapeutic agents Chemistry; Metallurgy 56 Active
US10022435B2 Nucleic acid vaccines Emerging Cross-Sectional Technologies 53 Active
US11045540B2 Varicella zoster virus (VZV) vaccine Chemistry; Metallurgy 52 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.